Figure 3From: Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover studySerial postprandial changes in glucose (A), TG (B), RLP-C (C), ApoB-48 (D), LDL-C (E), and HDL-C (F) in the control and bezafibrate groups. Data are expressed as mean ± SE. *p < 0.05 vs. control group.Back to article page